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1.0. INTRODUCTION 
The drug should be delivered to site at the specific target sites at a rate and 
concentration that permit optimal therapeutic efficacy while reducing side effects to 
minimum. The other aspect to be considered in drug delivery is patient compliance during the 
drug therapy. 
The concept of the advanced drug delivery systems especially those offering a 
sustained and controlled action of drug to desired area of effect, attained great appeal for 
nearly half a century. However, prior to advent of improved alternate methods, drug delivery 
systems were considered only as a means of getting the drug in to the patient’s body. The 
actual practice of controlled release began with advent of timed release coating to the pills or 
solid drug particles in order to mask their unacceptable taste or make them more palatable. 
In the mid 1940 - 1960s, the concept of chemical microencapsulation technology 
began as an alternative means of delivering drugs. In continued quest for the more refined 
systems, in 1980s polymer membrane technology came to be known at forefront. Further, the 
process of targeting and site specific delivery with absolute accuracy can be achieved by 
attaching bioactive molecule to liposomes, bio-erodible polymer, implants, monoclonal 
antibodies and various particulate carriers (e.g., nanoparticles and microspheres, etc.). The 
micro-particulate delivery systems are considered and accepted as a reliable means to deliver 
the drug to the target site with specificity, if modified and to maintain the desired 
concentration at the site of interest without untoward effect(s). 
The term microcapsule, which explains as a spherical particle with size varying from 
1µm to (1000 µm) 1 mm, containing a core substance. Microspheres comprises of strict 
sense, spherical empty particles. However, the terms microcapsules and microspheres are 
often used synonymously. 
1.1. Microspheres
1, 2, 20 
         A well designed controlled drug delivery system can overcome some of the problems 
of conventional therapy and enhance the therapeutic efficacy of a given drug. To obtain 
maximum therapeutic efficacy, it becomes necessary to deliver the drug to the target tissue in 
optimal amount at the right period of time thereby causing little toxic and minimal side 
effect
13
. There are various approaches in delivering a therapeutic substance to the site in a 
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sustained controlled release fashion. One such approach is using microspheres as carrier for 
drugs. 
Definition of Microspheres: 
The Microspheres are characteristically free flowing powders consisting of proteins or 
synthetic polymers, which are biodegradable in nature, and ideally having a particle size less 
than 200 µm
3
.solid bio degradable microspheres incorporating a drug and dispersed or 
dissolved throughout particle matrix have the potential for the controlled release of drugs. 
Microspheres are defined as homogeneous, monolithic particles in the size range of 
about 1µm-1000 µm and are widely used as drug carriers for controlled release. These 
systems have significant importance in biomedical applications. Microspheres can be 
produced for protection of core material, reduction of gastric irritation decrease in volatility, 
conversion of liquid to pseudo-solid, cell microencapsulation and for designing pulsatile drug 
delivery systems. Administration of the drug in the form of microspheres usually improves 
the treatment by providing the localization of the active substances at the site of action and by 
prolonging release of drugs. 
 Prerequisites for Ideal Carriers
3, 13 
 Longer duration of action  
 Control of drug release 
 Increased of therapeutic efficiency 
 Protection of drugs 
 Reduction of toxicity 
 Biocompatibity 
 Relative stability 
 Water solubility or dispersability 
 Targetability 
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1.2. Polymer used in Microspheres 
      These materials include the polymer of natural and synthetic origin and also modified 
natural substances  
 Synthetic Polymer 
a. Non-Biodegradable  
 Poly methyl methacrylate9 
 Acrolein11 
 Glycidyl methacrylate 
 b. Biodegradable 
 Lactides and glycolides and their copolymers25 
 Polyalkyl cyano acrylate 
 Natural Polymer 
  a. Proteins 
 Albumins29,31 
 Gelatin30   
 Collagen  
b. Carbohydrates 
 Starch24 
 Agarose 
 Carrageenan 
 Chitosan  
c. Chemically modified carbohydrates 
 Poly (acryl) dextran 
 Poly (acryl) starch 
In case of non-biodegradable drugs carriers, when administered parentrally the carrier 
remaining in the body after the drug is completely released poses possibity of carrier toxicity 
over a long period of time. Biodegradable carriers which degradable in the body to non-toxic 
degradation products do not pose the problem of carrier toxicity and are more suited for 
parenteral application
13
. 
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1.3. Route of Administration 
Microspheres can be used for the delivery of drugs via different routes. Route of 
administration is selected depending on the drug properties, disease state being treated and 
the age and condition of the patient. Desirable properties of the microspheres to be used for 
the delivery will also change depending on the route of administration. 
1.3.1 Oral Delivery: 
           Oral delivery is the simplest way of drug administration. In oral drug delivery, the 
microspheres have to pass through frequently changing environments in the GI tract. There’s 
also patient to patient variation in GI content, stomach emptying time and peristaltic activity. 
Although constraints of the oral route are numerous, on the whole, it offers less potential 
danger than the parenteral route. The relatively brief transit time of about 12 hrs through the 
GI tract limits the duration of action that can be expected via the oral route. Recently, it has 
been reported that microspheres of <10 µm in size are taken up by the payer’s patches and 
may increase the retention time in the stomach. Also microspheres made from polymers with 
mucoadhesive properties get attached the stomach and prolong the residence time in the 
stomach. Bioavailability of the drugs with limited solubility in the stomach or intestine and 
small absorption rate constant can be increased by increasing the retention time in the 
stomach. improved drug delivery was observed compared to the microspheres administered 
alone. 
1.3.2 Parenteral Delivery: 
Most of the microsphere based controlled delivery systems are developed with the 
aim of using them for parenteral administration. Drug released is completely absorbed in this 
case. Microspheres used for parenteral delivery should be sterile and should be dispersible in 
suitable vehicle for injection. Hydrophilic microspheres have the potential advantage of 
aqueous dispersibility as opposed to hydrophobic microspheres for reconstituting them for 
injection. Surfactants in small concentrations are often necessary for reconstituting 
hydrophobic particles for injection in aqueous vehicles which are reported to cause adverse 
tissue reactions and affect the release of incorporated drug. 
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Drug Loading and Drug Release Kinetics
 3, 13 
    The active components are loaded over the microspheres principally using two 
methods, i.e. during the preparation of microspheres or after the formation of the 
microspheres by incubating them with the drug protein. The active components can be loaded 
by means of the physical entrapment, chemical linking and surface adsorption. The 
entrapment largely depends on the method of preparation and nature of the drug or polymer. 
 Maximum loading can be achieved by incorporating the drug during the time of 
preparation but it may get affected by many other process variables such as method of 
preparation, presence of additives (e.g. cross linking agent,surfactant,stabilizers,etc.) heat of 
polymerization, agitation intensity etc. Release of the active constituents is an important 
consideration is case of microspheres. 
 
Mechanism of Drug Release
1, 3, 13 
 Osmotically driven burst mechanism 
 Pore diffusion  mechanism 
 Erosion or degradation of the polymer 
   
a) Osmotically Driven Burst Mechanism: 
   Water diffuse into the core through biodegradable or non-biodegradable coating, 
creating sufficient pressure that ruptures the membrane. The burst effect is mainly controlled 
by three factors the macromolecules/Polymer ratio, particle size of the dispersed 
macromolecule and the particle size of the microspheres. 
b) Pore Diffusion Method: 
     Penetrating water front continue to diffuse towards the core. 
c) Erosion: 
    Loss of polymer is accompanied by accumulation of the surrounding release medium. 
The erosion of the polymer begins with the changes in the microstructure of the carrier as 
water penetrates within it leading to the plasticization of the matrix. 
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1.4. General Methods of Preparation
1, 3 
    The Microsphere can be prepared by using any of the several techniques discussed in 
the following  
 Single emulsion technique 
 Double emulsion technique 
 Polymerization technique 
a. Normal polymerization  
 Bulk polymerization 
 Suspension polymerization 
 Emulsion polymerization 
b. Interfacial polymerization 
 Phase separation coacervation techniques 
 Spray drying and spray congealing 
 Solvent extraction 
 Solvent evaporation technique 
But the choice of technique mainly depend on the nature of polymer used, the drug, the 
intended use and the duration of therapy 
Some formulation and technology related factors are mentioned below 
 The particle size requirement 
 The drug or the protein should not be adversely affected by the process 
 Reproducibility of the release profile and method  
 No stability problem 
 There should be no toxic products associated with the final product. 
 
Method of Preparation 
    Preparation of Microsphere should satisfy certain criteria: 
 The ability to incorporate reasonably high concentration of the drug 
 Stability of the preparation after synthesis with a clinically acceptable shelf life 
 Controlled particle size and dispersability in aqueous vehicles for injection 
 Release of active drug with a good control over a wide time scale. 
 Biocompatibility with a controllable biodegradability and 
 Susceptibility to chemical modification. 
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Single Emulsion Technique: 
     The micro particulate carriers of natural polymers i.e. those of proteins and 
carbohydrates are prepared by single emulsion technique. The natural polymer are dissolved 
or dispersed in aqueous medium followed by dispersion in non-aqueous medium like liquid 
paraffin. 
Next cross linking of the dispersed globule is carried out. The cross linking is 
achieved either by means of heat or by using the chemical cross linkers. E.g. the chemical 
cross linking agents are glutaraldehyde, formaldehyde, Di acid chloride etc. 
Disadvantages  
 Heat denaturation is not suitable for thermolabile substance. 
 Chemical cross linking suffers the excessive exposure of active ingredient to 
chemicals if added at the time of preparation and then subjected to centrifugation, 
washing and separation. 
 
Double Emulsion Technique: 
     Double emulsion method of involves the formation of the multiple emulsions or the 
double emulsion of type w/o/w and is best suited for water soluble drugs, peptides, proteins 
and vaccines. 
 This method can be used with both the natural as well as synthetic polymers. The 
aqueous protein solution is dispersed in a lipophilic organic continuous phase. This protein 
solution may contain the active constituents. The continuous phase generally consisted of the 
polymer solution that eventually encapsulates of the protein contained in dispersed aqueous 
phase. 
The primary emulsion is subjected then to the homogenization or the sonication 
before addition to the aqueous solution of the poly vinyl alcohol (PVA).This results in the 
formation of a double emulsion. The emulsion is then subjected to solvent removal either by 
solvent evaporation or by solvent extraction. A number of hydrophilic drugs like LH-RH 
agonist, vaccines proteins/peptides and conventional molecules are successfully incorporated 
into the microspheres using the method of double emulsion solvent evaporation/extraction. 
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Polymerization Techniques 
    The polymerization techniques conventionally used for the preparation of the microspheres 
are mainly classified as: 
         a. Normal polymerization  
         b. Interfacial polymerization both are carried out in liquid phase. 
a. Normal Polymerization  
     It is carried out using different technique as bulk, suspension, precipitation, 
Emulsion and micellar polymerization. 
 Bulk Polymerization Technique 
Monomer or a mixture of monomer along with the initiate polymerization. Polymer so 
obtained may be moulded as microspheres. Drug loading may be done during the process 
of polymerization. 
 Suspension Polymerization Technique 
Suspension polymerization also referred as bead or pearl polymerization is carried out 
by heating the monomer or mixture of monomer as droplets dispersion in a continuous 
aqueous phase. The droplet may also contain an initiator and other additives. 
 Emulsion Polymerization Technique 
It is differs from suspension polymerization  as due to the presence initiator in the 
aqueous phase, which later on diffuses to the surface of micelles. 
b. Interfacial Polymerization 
      It involves the reaction of various monomers at the interface between the two 
immiscible liquid phases to from a film of polymer that essentially envelopes the dispersed 
phase. 
 
Phase Separation Coacervation Technique: 
      This process is based on the principle of decreasing the solubility of the polymer in 
organic phase to affect the formation of polymer rich phase called the coacervates. 
In this method, the drug particles are dispersed in a solution of the polymer and an 
incompatible polymer is added to the system which makes first polymer to phase separate and 
engulf the drug particles. Addition of non-solvent result in the solidification of polymer. 
  Poly lactic acid (PLA) microspheres have been prepared by this method by using 
butadiene as incompatible polymer. The process variables are very important since the rate of 
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achieving the coacervates determines the distribution of the polymer film, the particle size 
and agglomeration of the formed particle. 
   The agglomeration must be avoided by stirring the suspension using a suitable speed 
stirrer since  as the process of microspheres formation begins the formed polymerize globules 
start to stick and form the agglomerates. Therefore the process variables are critical as they 
control the kinetics of the formed particles since there is no defined state of equilibrium 
attainment. 
 
Spray Drying and Spray Congealing 
   These methods are based on the drying of the mist of the polymer and drug in the air. 
Depending upon the removal of the solvent or cooling of the solution, the two processes are 
named spray drying and spray congealing respectively. 
   The polymer is first dissolved in a suitable volatile organic solvent such as 
dichloromethane, acetone, etc. The drug in the solid form is then dispersed in the polymer 
solution under high speed homogenization. This dispersion is then atomized in a stream of 
hot air. The atomization leads to the formation of the small droplets or the fine mist from 
which the solvent evaporates instantaneously leading the formation of the microspheres in a 
size range 1-100µm. 
    Microparticles are separated from the hot air by means of the cyclone separator while 
the trace of solvent is removed by vacuum drying. 
Advantage     
   Feasibility of operation under aseptic condition. The spray drying process is used to 
encapsulate various penicillin’s. Thiamine mononitrate of mono and diglycerides of stearic 
acid and palmitic acid using spray congealing. Very rapid solvent evaporation, however leads 
to the formation of porous microparticles. 
Solvent Extraction  
    Solvent extraction method is used for the preparation of microparticles, involves 
removal of the organic phase by extraction of organic solvents such as isopropanol .organic 
phase is removed by extraction with water. This process decrease the hardening time for the 
microspheres. 
   One variation of the process involves direct addition of drug or protein to polymer 
organic solution. The rate of solvent removal by extraction method depends on the 
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temperature of water, ratio of emulsion volume to the water and the solubility profile of the 
polymer. 
Solvent Evaporation
1, 4 
     Solvent evaporation is carried out by maintain emulsion at reduced pressure or by 
stirring the emulsion so that the organic phase evaporation out. In the latter case, the 
emulsion is added to the large quantity of water into which organic phase diffuse out. The 
solid microspheres are subsequently obtained by filtration and washing. 
Advantage 
 High encapsulation efficiency of moderately water soluble and water-insoluble 
compounds 
 Water soluble drugs such as theophylline, caffeine, and salicylic acid could be loaded 
efficiently using an o/o emulsion method. 
 Versatile and easy 
 It’s possible to achieve various drug release profiles by the regulation of copolymer 
ratio, molecular weight, and size of the microsphere, drug loading, porosity and other 
formulation parameter. 
 
1.5. Applications of Microspheres
1, 3, 13
: 
Microspheres in Vaccine Delivery: 
          The prerequisite of a vaccine protection against the microorganism or its toxic 
product. An ideal vaccine must fulfill the requirement of efficacy, safety, convenience in 
application and cost. The aspect of safety and minimization of adverse reaction is a complex 
issue. The aspect of safety and the degree of the production of antibody responses are closely 
related to mode of application. Biodegradable delivery systems for vaccines that are given by 
parenteral (subcutaneous, intramuscular, intradermal) carrier lies since they offer specific 
advantages like: 
 Improved antigenicity by adjuvant action  
 Modulation of antigen release 
 Stabilization of antigen 
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Targeting Using Micro particulate Carriers 
           The concept of targeting i.e. site specific drug delivery is a well-established dogma, 
which is gaining full attention. The therapeutic efficacy of the drug release on its access and 
specific interaction with its candidate receptors. The ability to leave the pool in reproducible, 
efficient and specific manner is center to drug action mediated by use of a carrier system. 
Placement of the particles indiscrete anatomical compartment leads to their retention either 
because of the physical properties of the environment or biophysical interaction of the 
particle with the cellular content of the target tissue. 
 
Monoclonal Antibodies Mediated Microspheres Targeting  
          Monoclonal antibodies targeting microspheres are immuno microspheres. This 
targeting is a method used to achieve selective targeting to the specific sites. Monoclonal 
antibodies are extremely specific molecule. This extreme specificity of monoclonal 
antibodies (Mabs) can be utilized to target microspheres loaded bioactive molecule to 
selected sites. Mabs can be directly attached to the microspheres by means of covalent 
coupling. The free aldehyde groups, amino groups or hydroxyl groups on the surface of the 
microspheres can be linked to the antibodies. The Mabs can be attached to microspheres by 
any of the following methods 
 Non specific adsorption  
 Specific adsorption  
 Direct coupling  
 Coupling via reagent 
Chemoembolization  
          Chemoembolization is an endovascular therapy, which involves the selective arterial 
embolization of a tumor together with simultaneous or subsequent local delivery the 
chemotherapeutic agent. The theoretical advantage is that such embolizations will not only 
provide vascular occlusion but will bring about sustained therapeutic levels of 
chemotherapeutics in the areas of the tumor. Chemoembolization is an extension of 
traditional percutaneous embolization techniques. 
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Imaging  
      The microspheres have been extensively studied and used for the targeting purposes. 
Various cells, cell lines, tissue and organs can be imaged using radio labeled microspheres. 
The particle size range of Microspheres is an important factor in determining the imaging of 
particular sites. The particle injected intravenously apart from the portal vein will become 
entrapped in the capillary bed of the lungs. This phenomenon is ex0ploited for the 
scintiographic imaging of the tumor masses in lungs using labeled human serum albumin 
microspheres. 
 
Topical Porous Microspheres 
  Microsponges are porous microspheres having myriad of interconnected voids of 
particle size range 5-300 µm. These microsponges having capacity to entrap wide range of 
active ingredients such as emollients, fragrances, essential oils etc., are used as the topical 
carriers system further, these porous microspheres with active ingredient can be incorporated 
into formulation such as creams, lotions and powders. Microsponges consist of non-
collapsible structures with porous surface through which active ingredients are released in a 
controlled manner. 
 
Surface Modified Microspheres 
                  Different approaches have been utilized to change the surface properties of carriers to 
product them against phagocytic clearance and to alter their body distribution patterns. The 
adsorptions of the poloxamer on the surface of the polystyrene, polyester or poly methyl 
methacrylate microspheres renders them more hydrophilic and hence decrease their MPS 
uptake. Protein microspheres covalently modified by PEG derivatives show decreased 
immunogenicity and clearance.  
           The most studied surface modifiers are: 
 Antibodies and their fragments 
 Proteins 
 Mono, oligo and polysaccharides 
 Chelating compounds (EDTA,DTPA or Desferroxamine) 
 Synthetic soluble polymers  
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Such modification are provided surface of microspheres in order to achieve the targeting to 
the discrete organs and to avoid rapid clearance from the body. 
 
1.6. Mucoadhesion
3, 4
: 
Mucoadhesion is a promising approach in the design of the drug delivery systems to 
prolong the residence time of the dosage form the site of application or absorption and to 
facilitate intimate contact of the dosage form with the underlying absorption surface to 
improve and enhance the bioavailability of drugs. Several studies reported mucoadhesive 
drug delivery systems in the form of tablet, films, patches and gels for oral, buccal, nasal, 
ocular, and topical routes. 
Oral route is the most convenient route for the delivery of most of the drugs because 
of more flexibility in designing of dosage form and administration of the dosage form. The 
oral drug delivery systems (DDS) designing depends upon various parameters such as type of 
delivery system, type of disease treated, length of the therapy, patient, properties of the drug. 
The main drawback of the conventional dosage forms is frequent administration of dosage 
form and targeting of the drug is not possible. To overcome this drawback novel drug 
delivery systems are developed. These novel drug delivery systems are of two types viz. 
Controlled drug delivery systems (CDDS), targeted drug delivery systems. CDDS will 
release the drug in a controlled manner in the GIT and they are not specifically delivering the 
drug to GIT sites. But in case of targeted drug delivery systems the drug will be released to a 
particular site of the GIT, e.g. colon specific DDS. 
Bio adhesive is the term that describes the adhesion of a polymer to a biological 
substrate. If the polymer is adhered to lining of mucosal surface then it is known as 
mucoadhesion. When the dosage form adheres to mucus membrane or biological membrane 
it results in immobilization of drug carrying particles at the mucosal surface. Mucoadhesive 
or bio adhesive controlled release systems improve the effectiveness of a drug by maintaining 
the drug concentration between the effective and toxic levels, inhibiting the dilution of the 
drug in the body fluids, and allowing targeting and localization of a drug at specific site. Bio 
adhesive systems can prevent first pass metabolism of certain protein drugs by liver through 
the introduction of drug via route bypassing the digestive tract. 
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1.7. Fundamentals of Bioadhesion 
When the bio adhesive system come in contact with the biological membrane it forms 
an adhesive bond between the polymer and the biological membrane by forming contact 
between the two surfaces and forming secondary bonds by noncovalent interactions. The 
bond formation between polymer and membrane depends upon properties of polymer and 
biological membrane. 
Bioadhesive Polymers: 
The bio adhesive property of the polymer depends upon various properties of the 
polymer. The properties involved are, molecular weight of the polymer, chain length and 
cross-linking density of the polymer, charges and ionization, hydrophilic functional groups 
and degree of hydration. 
Two classes of polymers appear to be of interest for bio adhesion: hydrophilic 
polymers and hydrogels. The large class of hydrophilic polymers, those containing carboxyl 
groups exhibits the best bio adhesive properties Bio adhesive polymers include sodium 
alginate, methylcellulose, carboxy methyl cellulose, hydroxy methyl cellulose, and cationic 
hydrogels such as chitosan. In general, hydrogels have most often been used for bio adhesive 
drug delivery because of the belief that polymer-mucin chain entanglement is an essential 
component in bio adhesive bond formation. However, other factors, such as surface energy, 
surface texture, electrical charge, and hydrophilic functional groups, may be equally 
important. It has recently been shown that nonhydrogel polymers that are high in hydrophilic 
functional groups can also produce intense bio adhesive interactions and can be utilized to 
improve bioavailability of orally administered compounds. 
 
1.8. Mechanism of Bioadhesion
23 
The mechanisms responsible in the formation of bio adhesive bonds are not fully 
known, however most research has described bio adhesive bond formation as a three step 
process. 
Step 1: Wetting and swelling of polymer 
Step 2: Interpenetration between the polymer chains and the mucosal membrane 
Step 3: Formation of chemical bonds between the entangled chains. 
 
INTRODUCTION 
 
Department of Pharmaceutics, Nandha College of Pharmacy, Erode-52. Page 15 
 
Wetting and Swelling of Polymer (Wetting Theory): 
The wetting and swelling step occurs when the polymer spreads over the surface of 
the biological substrate or mucosal membrane in order to develop an intimate contact with the 
substrate. The ability of the adhesive to spread spontaneously on mucin influences 
development of intimate contact between the mucoadhesive and mucin and consequently 
influences the mucoadhesive strength. Bio adhesives are able to adhere to or bond with 
biological tissues by the help of the surface tension and forces that exist at the site of 
adsorption or contact. Swelling of polymers occurs because the components within the 
polymers have an affinity for water. 
 
Fig: Swelling of a polymer 
 
 
Interpenetration between the Polymer Chains and the Mucosal Membrane (Diffusion 
Theory): 
The surfaces of mucosal membranes are composed of high molecular weight 
polymers known as glycoproteins. In step 2 of the bio adhesive bond formation, the bio 
adhesive polymer first brought into intimate contact with the mucous and over time the 
concentration gradient across interface causes the diffusion of the chains of the bio adhesive 
into mucous layer and also the diffusion of glycoprotein chains of the mucous into the bio 
adhesive polymer. 
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Fig: The interpenetration of polymer chains 
Formation of Chemical Bonds between the Entangled Chains: 
This step involves the formation of weak chemical bonds between the entangled 
polymer chains. The types of bonding formed between the chains include primary bonds such 
as covalent bonds and weaker secondary interactions such as Vander Waals Interactions and 
hydrogen bonds. Both primary and secondary bonds are exploited in the manufacture of bio 
adhesive formulations in which strong adhesions between polymers are formed. 
 
 
 
 
Mechanisms of bio adhesion: 
The formation of bond between bio adhesive polymer and mucous layer can also be 
explained by electronic theory. The mucin glycoprotein and mucoadhesive polymers possess 
different electronic structures; therefore electronic transfer is likely to occur when contact is 
made. This electron transfer results in formation of electric double layer at the adhesive 
interface with subsequent adhesion. 
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Factors affecting on Mucoadhesion 
1. Polymer related factors: 
i) Molecular weight 
ii) Concentration of active polymer 
iii) Flexibility of polymer chains 
iv) Special confirmation 
v) Swelling 
2. Environment related factors: 
i) pH of polymer - substrate interface 
ii) Applied strength 
iii) Initial contact time 
3. Physiological factors: 
i) Mucin turns over 
ii) Disease state 
Bioadhesion Advantages: 
Advantages and applications of oral bio adhesive dosage forms are as follows: 
a) Bio adhesive drug delivery systems can prolong GI transit time and improving oral 
drug absorption should ideally be nontoxic, non-absorbable from the GI tract. 
b) They prolong the residence time at the site of action or absorption. 
c) Preferably form a strong non-covalent bond with mucin-epithelial cell surfaces 
thereby they adhere to the tissues and cause localized drug release. 
d) Adhere quickly to moist tissue. 
e) Allow easy incorporation of drug and offer no hindrance to its release. 
f) If pH sensitive polymers are used as bio adhesive material, the system will attach to 
pH specific sites and release the drug at those sites i.e. site specific drug delivery is 
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possible. 
g) Economical: 
Most of the routes of administration like ocular, nasal, rectal, buccal, respiratory, 
vaginal, are coated with the mucus layer, mucoadhesives increase the residence time and 
provide intimate contact between a dosage form and the absorbing tissue which results in 
high drug concentration in a local area and high drug flux through the absorbing tissue. The 
intimate contact may increase the total permeability of the high molecular weight drugs like 
proteins and peptides. 
Microencapsulation: 
It has been accepted as a process to achieve controlled release and drug targeting. 
Mucoadhesion has been a topic of interest in the design of drug delivery to prolong the 
residence time of dosage form at the site of application or absorption and to facilitate intimate 
contact of the dosage form with the underlying absorption surface to improve and enhance 
the bioavailability of drugs. 
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2.0. LITERATURE REVIEW 
Alagusunduram. M et al., (2009)
2
 studied Microspheres are characteristically free flowing 
powders consisting of proteins or synthetic polymers which are biodegradable in nature and 
ideally having a particle size less than 200 μm. A well designed controlled drug delivery 
system can overcome some of the problems of conventional therapy and enhance the 
therapeutic efficacy of a given drug. There are various approaches in delivering a therapeutic 
substance to the target site in a sustained controlled release fashion. One such approach is 
using microspheres as carriers for drugs. It is the reliable means to deliver the drug to the 
target site with specificity, if modified, and to maintain the desired concentration at the site of 
interest without untoward effects. Microspheres received much attention not only for 
prolonged release, but also for targeting of anticancer drugs to the tumor. In future by 
combining various other strategies, microspheres will find the central place in novel drug 
delivery, particularly in diseased cell sorting, diagnostics, gene & genetic materials, safe, 
targeted and effective in-vivo delivery and supplements as miniature versions of diseased 
organ and tissues in the body. 
 
Meral Yuce et al., (2008)
12
 studied the Indomethacin loaded microspheres of ethyl cellulose 
were prepared by the emulsion solvent evaporation techniques. The aim of this work was to 
investigate the influence of process variation polymer type via viscosity grade of ethyl 
cellulose. Microspheres exhibited lower burst effect with decreased drug release rate, when 
the drug was incorporated with ethyl cellulose N100 and higher ratio of each polymer. 
Therefore Indomethacin release from ethyl cellulose microspheres could not be evaluated by 
any of the kinetic models. 
 
Suja cjayan et  al., (2009)
14
 studied about gelatin microspheres containing salbutamol 
sulphate prepared by coacervation phase separation method. And microspheres were 
characterized by optical microscopy and scanning electron microscopy. The microspheres 
were analyzed for drug entrapment and in-vitro release pattern. The batches of microspheres 
were prepared by altering drug polymer ratio and cross linking with glutaraldehyde. The size 
of microspheres was in the range of 5.6 m-22.4 mm the average diameter was found to be 
12.34 mm. They were spherical in shape as evidenced by scanning microscopic photographs. 
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The percent drug entrapment was up to 80% and they could sustain drug release over a period 
of 8 and half hours 
 
Malay and Das et al., (2006)
15
 designed diltiazem loaded mucoadhesive   micro spheres by 
emulsification, internal gelatin techniques with a maximum incorporation efficiency of 93.29 
± 0.26% the scanning electron microscopy indicated that the microspheres were spherical in 
shape and drug remained dispersed in the polymer matrix. The in-vitro drug release 
mechanism was non-fickian type controlled by swelling and relaxation of polymer.  There 
was no significant change in drug content and cumulative drug release of drug loaded 
microspheres stored at different storage conditions after 8 weeks of study.   
Rajendra Kotadiya et al., (2009)
 20
 studied the theophylline loaded agar microspores. The 
effect of hydrocolloid on the physicochemical properties of the microspheres was 
investigated. The similar result of prepared formulation (t50=211.78) and marketed product 
(t50=209.29) suggest sustained release of the drug. 
Rossoul dinarvand et al., (2005)
21, 49
 prepared gelatin micro spheres by polymerization 
techniques using glutaraldehyde as the cross linking agent. They investigated the effect of 
time of cross linking and amount of cross linking agent on the swelling properties of micro 
spheres and their release. The micro encapsulation efficiency micro spheres appearance, 
particle size, swelling ratio and drug release profile were also studied micro spheres with 
larger amount of cross linking agent showed reduced swelling ratio. In-vitro release pattern of 
lactic acid from gelatin micro spheres showed lymphatic profile and release rates were 
reduced upon increasing the amount of cross linking agent. 
Shiv Shankar Hardenia et al., (2011)
32
 developed ethyl cellulose microspheres containing 
ciprofloxacin were prepared and evaluated for in-vitro performance of ciprofloxacin. 
Ciprofloxacin microspheres containing ethyl cellulose were prepared by emulsion solvent 
diffusion evaporation method. The surface morphological characteristics of ethyl cellulose 
microspheres were investigated using scanning electron microscopy. The polymer ratio, 
stirring speed and the temperature affected the particle size, shape and surface morphology of 
the microspheres. The in-vitro drug release was carried out using USP paddle type dissolution 
rate test apparatus in 0.1N HCL dissolution medium at 291 nm. It was found that drug release 
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from the formulations was different at different concentrations of polymers and different 
RPM and temperature. The best cumulative release was achieved after 24 hrs i.e. 91.6%. The 
Mucoadhesive property of the ethylcellulose microspheres was evaluated by in-vitro wash off 
test. The microspheres exhibited 75% mucoadhesion and showed good drug entrapment 
efficiency. By, above results it was concluded that ethyl cellulose microspheres showed 
reproducible results, with good Mucoadhesive properties and good surface morphology. 
 
Bagherwal A et al., (2010)
41
 Ciprofloxacin HCl belong to the fluoroquinoline derivatives 
which is widely used in the long term therapy for treatment of a wide range of infections 
including anthrax, biliary tract infection, bone and joint infection, gastrointestinal including 
traveler’s diarrhea and Campylobacter enteritis, Shiegella, meningococcal meningitis 
prophylaxis, surgical infection prophylaxis, tuberculosis, leprosy and topically in the 
treatment of eye infections. Hence there is a potential need for floating tablet as sustained 
release dosage form for this drug. HPMC and carbomer are the polymers, used as suspending 
agent, viscosity increasing agent and tablet binder coating agents. In the present study, it was 
aimed to formulate floating tablet of ciprofloxacin HCl with HPMC and carbomer in different 
proportion (4%, 8% and 12%) by direct compression techniques using polymers lactose, 
Magnesium Streate, talc with sodium bicarbonate. All the prepared formulation were found to 
complies with the official tests like precompression parameter like angle of repose and post 
compression parameters like Shape, tablet dimensions, hardness, friability test, weight 
variation test, floating test, content uniformity and in-vitro dissolution study. In-vitro release 
studies were carried out using USP XXII dissolution test apparatus. The mean percentage of 
ciprofloxacin released at various time intervals was calculated and plotted against time. The 
mechanism of drug release with all the formulations was dominantly diffusion and followed 
zero order kinetics. It was observed that the integrity of the drug is not affected by 
formulation procedure. The results revealed the drug polymer ratio showed greater drug 
release than other formulations. 
 
Hai H. Pham et al., (2002)
42
 this investigation synthesized and characterized hydroxyapatite 
(HAP) microspheres, agglomerated microspheres, and implants containing ciprofloxacin. 
This delivery system is to be used as an implantable drug delivery system for the treatment of 
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bone infections. The HAP microspheres were made by chemical precipitation followed by a 
spray-drying technique. Agglomerated microspheres were prepared by a wet granulation 
process using a granulator. Implants were prepared by direct compression of the granules on 
a Carver press. Ciprofloxacin was analyzed by high-performance liquid chromatography. 
Characterizations of the HAP microspheres include particle size, size distribution, physical 
state of the drug in the microsphere, and microstructure of the drug delivery system before 
and after in vitro release. The particle size, porosity, and morphology of the microspheres 
were dependent on viscosity and concentration of the slurry as well as the atomization 
pressure used during spray drying. Even at the highest drug load (2% wt/wt), the drug was 
present in a noncrystalline state. The drug release from the agglomerated microspheres was 
quick and almost complete within 1 hour. However, Compressing the same amount of 
agglomerated microspheres into an implant greatly reduced the rate of ciprofloxacin release. 
Only 12% (wt/wt) of the drug was released from the implant within 1hr. 
Jeong YI et al., (2009) created ciprofloxacin HCl (CIP)-encapsulated poly (DL-lactide -co-
glycoside) (PLGA) microspheres by the solvent evaporation method. Their antibacterial 
activity was evaluated with pathogenic microorganisms in vitro and in vivo. Since the half-
life of CIP in the blood stream is short, sustained-release properties of microspheres may 
provide enhanced antibacterial activity. CIP- encapsulated microspheres of PLGA were 
prepared by the O/O method. CIP-encapsulated PLGA microspheres showed spherical shapes 
under a scanning electron microscope (SEM) and their particle sizes ranged from 10 to 50 
micron. In an in vitro drug release study, CIP was continuously released over 3 weeks from 
the microspheres, and a burst effect was observed for the first 3 days. In the in vitro 
antibacterial activity test, CIP-microspheres showed lower antibacterial activity compared to 
free CIP because of their sustained-release properties, while empty microspheres did not 
affect the growth of microorganisms. In the in vivo antibacterial activity test, the number of 
microorganisms following treatment with CIP- encapsulated microspheres was significantly 
lower than after treatment with free CIP at 5 days post injection. These results suggest that 
encapsulated CIP keeps its antibacterial activity after microencapsulation. 
Ravindra J. Salunke et al., (2009)
43
 the current study was to develop and optimize a Hydro 
dynamically balanced system of ciprofloxacin HCL as a single unit capsules using response 
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surface methodology. Ciprofloxacin HCl has an absorption window in the stomach and in the 
upper part of the small intestine. A 32 full factorial design was employed to optimize the 
formulation wherein hydroxylpropyl methyl cellulose K4M (HPMC K4M) (X1) and 
Carbopol 934 (X2) were taken as independent variables and amount of drug release after 12 
hrs (Y1), t50 (Y2), and t85 (Y3) were taken as the dependent variables. The capsules were 
prepared by physical blending of drug and the polymers in varying ratios. The release data 
were evaluated by the model dependent (curve fitting) method using the PCP Disso v2.08 
software. Optimization studies were carried out using the Design Expert Software (Version 
7.1.6). Formulations were evaluated for in vitro buoyancy and in vitro release studies. The in 
vitro drug release followed zero order kinetics and the drug release mechanism was found to 
be anomalous or non-fickian type. It was found that both HPMC and Carbopol and their 
interaction had significant impact on the release and floating properties of the delivery 
system. The similarity factor f2 was found to be 62.32 for the developed formulation 
indicating the release was similar to that of the marketed formulation (Cifran). Thus, a 
combination of HPMC K4M and Carbopol 934 can be used to increase the gastric residence 
time and drug release for a period of 12hrs. 
 
Dhakar R. C. et al., (2010)
44
  envisaged to reduce the dosing frequency and improve patient 
compliance by designing and evaluating Sustained Release Mucoadhesive (SRM) 
microspheres of Metformin hydrochloride (MH) for effective control of diabetes type-2. 
Microspheres were prepared by emulsification solvent evaporation method using Sodium 
carboxy methyl cellulose (SCMC), Carbopol 934P (CP) and Hydroxyl propyl methyl 
cellulose K4M (HPMC) as mucoadhesive polymers. Microspheres prepared were found 
discrete, spherical and free flowing. The microspheres exhibits good mucoadhesive properties 
and showed high drug entrapment efficiency. MH release from these microspheres was slow 
and extended and dependent on the type of polymer used. The mean particle size decreased 
and the drug release rate increased at higher Stirring speed of emulsion content. Among all 
the formulations, formulation F1 containing SCMC and F2 containing CP showed the best 
reproducible results and mucoadhesive profile with good surface morphology. The data 
obtained thus suggest that mucoadhesive microspheres can successfully design for sustained 
delivery of MH and to improve patient compliance. 
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Faizi Muzaffar et al., (2010)
45
 Mucoadhesive microspheres include microparticles and 
microcapsules (having a core of the drug) of 1-1000μm in diameter and consisting either 
entirely of a mucoadhesive polymer or having an outer coating of it, respectively. 
Amoxicillin microspheres were formulated by using solvent evaporation technique. Using 
Eudragit RS 100 as matrix polymer. Evaluation of the prepared mucoadhesive microspheres 
was done for % yield, particle size analysis, particle size distribution angle of repose, and 
determination of drug content, shape, surface characterization, drug entrapment and finally 
cumulative drug release from microspheres by suitable and reliable official methodologies. 
 
Arunachalam.A et al., (2010) in the present study, gelatin microspheres containing oflaxacin 
were prepared by coacervation phase separation method and characterized by optical 
microscopy and scanning electron microscopy. The microspheres were analyzed for drug 
entrapment, bulk density, angle of repose, particle size and In-vitro release pattern. The effect 
of process variables on microsphere size was studied and based on these preliminary studies, 
different batches of microspheres were prepared by altering the drug: polymer ratio and 
cross-linking with glutaraldehyde. The size of microspheres was in range of 42- 45 μm. They 
were spherical in shape as evidenced by photomicrographs and scanning electron 
microscopy. The percent drug entrapment was in the range of 78-90 % and they could sustain 
drug release over a period of 8 hrs. 
 
Sindhuri.P et al., (2011)
46
Norfloxacin a fluoroquinoline derivative used as antibiotic 
requires multiple administration of drug, leading to fluctuation in plasma concentrations. The 
aim of present study is to formulate for sustained drug release. Norfloxacin microspheres 
(NM), by using various polymers like carbopol 934, Sodium Carboxy Methyl Cellulose 
(SCMC) using different drug: polymer ratios. Six formulations were prepared by using 
multiple emulsion solvent evaporation technique. NM were evaluated for parameters like 
angle of response, bulk density, particle size, drug content in microspheres, drug loading, 
encapsulation efficiency, In-vitro drug release studies. The prepared NM showed good flow 
properties, where spherical in shape with uniform surface morphology NM showed sustained 
release of the drug from the formulation for a period of 12 hours. 
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Pham H H et al., (2002) synthesized and characterized hydroxyapatite (HAP) microspheres, 
agglomerated microspheres, and implants containing ciprofloxacin. This delivery system is to 
be used as an implantable drug delivery system for the treatment of bone infections. The HAP 
microspheres were made by chemical precipitation followed by a spray-drying technique. 
Agglomerated microspheres were prepared by a wet granulation process using a granulator. 
Implants were prepared by direct compression of the granules on a Carver press. 
Ciprofloxacin was analyzed by high-performance liquid chromatography. Characterizations 
of the HAP microspheres include particle size, size distribution, physical state of the drug in 
the microsphere, and microstructure of the drug delivery system before and after in vitro 
release. The particle size, porosity, and morphology of the microspheres were dependent on 
viscosity and concentration of the slurry as well as the atomization pressure used during spray 
drying. Even at the highest drug load (2% wt /wt), the drug was present in a noncrystalline 
state. The drug release from the agglomerated microspheres was quick and almost complete 
within 1 hour. However, compressing the same amount of agglomerated microspheres into an 
implant greatly reduced the rate of ciprofloxacin release. Only 12% (wt/wt) of the drug was 
released from the implant within 1 hour. The in vitro release of ciprofloxacin from these 
implants follows a diffusion-controlled mechanism. This method provides a unique way of 
producing various shapes and drug loads of HAP microspheres that can be easily 
manufactured on a commercial scale. 
Venugopal Darak et al.,(2011)
47
 A simple, Rapid and Reproducible HPLC method has been 
developed for the estimation of Mesalamine in bulk drug and its Pharmaceutical dosage 
forms using RP C18 column. The mobile phase consists of Acetonitrile and water in the ratio 
of 60:40 v/v and was pumped at a flow rate of 0.6 ml/min at 25±1
o
c. The detection was 
carried out at 330 nm and the calibration curve was linear in the range of 20-100 μg/ml, 
Retention time was found to be 3.09 min for run time of 5 min. The method was statistically 
validated for its linearity, Precision and accuracy. Intra and Inter-day variation study was 
carried out and found to be less than 3% showing reasonable precision of the assay method. 
Parameters of validation obtained prove the accuracy of the method and its applicability for 
the determination of Mesalamine in tablet dosage formulations. 
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Duygu Gurcan et al., (2010) study was to evaluate ciprofloxacin hydrochloride-loaded 
chitosan microspheres for nasal administration. Microspheres were prepared by spray drying 
method and evaluated with respect to the particle size, morphological properties, drug-
polymer interaction, production yield, drug content, encapsulation efficiency, in-vitro drug 
release and kinetic assessment and in-vivo bioavailability. The particle size of microspheres 
prepared ranged from 3.3 to 6.7 μm. The microspheres showed spherical shape and smooth 
surface. For all formulations, drug loading capacity and microsphere yield were higher than 
74% and 38%, respectively. Based on in-vitro evaluation of microspheres, the most suitable 
formulation has chosen for in vivo nasal application to rats. In-vivo studies showed that, 
absolute bioavailability of CIPRO formulations (oral solution, nasal solution and nasal 
microsphere suspension) were found as 8.57%, 15.7% and 32.9%, respectively. According to 
the obtained data, CIPRO-loaded chitosan microspheres prepared with spray-drying method 
are able to prove sustained release and could be use via nasal route as an alternative to oral 
route. 
 
Tamizharasi S et al., (2009)
48
 prepared and evaluated poly (e-caprolactone) microspheres of 
Repaglinide by using the solvent evaporation techniques. The in-vitro release study showed 
that Repaglinide release from all formulations was slow and sustained over 12 hrs. 
Application of the in vitro drug release data to various kinetic equations indicated zero order 
release from Repaglinide microspheres. 
 
Fatemeh atyali et al., (2004)
49
 prepared ethyl cellulose coated gelatin microspheres of 5-
ASA. Gelatin and ethyl cellulose were used as primary and secondary polymer. Gelatin 
microspheres contain 5-amino salicylic acid was produced using solvent evaporation method. 
Gelatin microsphere showed no degradation in acidic medium. The gelatin microspheres 
were coated with ethyl cellulose by using co-acervation phase separation technique .The 
system provide suitable drug release pattern of active agent as 30% of the drug was released 
from the ethyl cellulose coated microcapsules within 6 hours while amount was 90% of the 
loaded drug for gelatin microspheres under the same condition.             
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3.0. DRUG AND POLYMER PROFILE 
  
 Drug Profile - CIPROFLOXACINE HCl
50
: 
Ciprofloxacin HCl is a synthetic fluroquinone antibiotic. 
Systematic (IUPAC) name: 1-cyclopropyl- 6-fluoro- 4-oxo- 7-piperazin- 1-yl- quinolone- 3- 
    Carboxylic acid.                              
Chemical data: 
Molecular formula  : C17H18FN3O3. HCl 
Molecular weight  :  331.346 
Structure: 
 
Fig:  Structure of Ciprofloxacin 
Physico-chemical properties: 
Description : Yellowish to light yellowish crystalline powder. 
Standards : Ciprofloxacin contains not less than 98.5 per cent and not more than of 101.5        
%, calculated on the dried basis. 
Solubility : Ciprofloxacin HCl is considered to be soluble in aqueous solutions with pH 
between 2 and 5. It is sparingly to slightly soluble in aqueous solutions with pH 7.4. 
Melting point : Ciprofloxacin HCl melts at 255-257
0 
C 
Pharmacokinetic data: 
Bioavailability : 69% 
Metabolism  : Hepatic, Including CYP1A2 
Half-life  : 4 hours 
Extraction  : Renal 
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Therapeutic considerations 
Availability 
Ciprofloxacin is available as: 
 tablets (250 mg, 500 mg or 750 mg) 
 intravenous solutions (5% and 10%, 100 ml) 
 eye and ear drops 
 In most countries, all formulations require a prescription. 
Routes : Oral, intravenous, topical (ear drop & Eye drops) 
Ciprofloxacin (INN) is a synthetic chemotherapeutic anti-biotic of the floroquinoline 
drug class. It is a second generation floroquinoline antibacterial. Kills bacteria by interfering 
with the enzymes that cause DNA to rewind after being copied, which stops DNA and protein 
synthesis. 
.STORAGE 
 Store at room temperature below 860 F (30o C) away from light and moisture. Do not store 
in the bathroom. Keep all medicines away from children and pets. 
 Do not flush medications down the toilet or pour them into a drain unless instructed to do 
so. Properly discard this product when it is expired or no longer needed. 
 Consult your pharmacist or local waste disposal company for more details about how to 
safely discard your product. 
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4.0. POLYMER PROFILE 
Polymer:  SODIUM CARBOXY METHYL CELLULOSE
33 
Grade     : Pharma Grade (Standards of IP 96) 
Prepared from cellulose by treatment with alkali and monochloro - acetic acid or its 
sodium salt. The article of commerce can be specified further by viscosity. 
Synonyms :  Sodium cellulose glycolate, Na CMC, CMC, cellulose gum, sodium CMC; 
Chemical names:  Sodium salt of carboxymethyl ether of cellulose 
Chemical formula:  [C6H7O2 (OH) x (OCH2COONa) y] n 
Where, 
n is the degree of polymerization 
x = 1.50 to 2.80 
y = 0.2 to 1.50 
x + y = 3.0 
(y = degree of substitution) 
Structural formula: 
 
Macromolecules: Greater than about 17,000 (n about 100) 
Assay: Not less than 99.5 % of sodium carboxymethyl cellulose, calculated on the dried basis. 
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Description:  White or slightly yellowish, almost odorless hygroscopic granules, powder 
         Or fine fibers. 
Functional uses: Thickening agent, stabilizer, suspending agent characteristics. 
Identification 
Solubility:  Yield viscous colloidal solution with water; insoluble in ethanol. 
Foam test: Vigorously shake a 0.1% solution of the sample. No layer of foam appears. This test 
distinguishes sodium carboxymethyl cellulose from other cellulose ethers and from alginates and 
natural gums. 
Precipitate formation:  To 5 ml of a 0.5% solutions of the sample add 5 ml of a 5% solution of 
copper sulfate or of aluminum sulfate. A precipitate appears. (This test permits the distinction of 
sodium carboxymethyl cellulose from other cellulose ethers and from gelatin, carob bean gum 
and tragacanth gum). 
Colour reaction:  Add 0.5 gm of powdered carboxymethylcellulose sodium to 50 ml of water, 
while stirring to produce a uniform dispersion. Continue the stirring until a clear solution is 
produced. To 1 ml of the solution, diluted with an equal volume of water, in a small test tube, 
add 5 drops of 1-naphthol TS. Incline the test tube and carefully introduce down the side of the 
tube 2 ml of sulfuric acid so that it forms a lower layer. A red-purple colour develops at the 
interface. 
Purity: Loss on drying not more than 12% after drying (105
o 
C to constant weight) 
pH: 6.0 - 8.5 (1 in 100 soln) 
Sodium: Not more than 12.4 % on the dried basis. Determine total sodium content by Atomic 
Absorption Spectroscopy or Flame Photometry. Sodium chloride not more than 0.5% on the 
dried basis See description under tests. 
Free glycolate: Not more than 0.4 % calculated as sodium glycolate on the dried basis 
Degree of substitution: Not less than 0.20 and not more than 1.50. 
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Lead:  Not more than 2 mg/ kg. Determine using an atomic absorption technique appropriate to 
the specified level. The selection of sample size and method of sample preparation may be based 
on the principles of the method described in “Instrumental Methods.” 
Properties Uses and Applications 
Sodium Carboxy Methyl Cellulose is an anionic water soluble polymer derived from 
cellulose. It is odorless, tasteless and nontoxic. It has the following properties making it useful in 
a wide variety of applications. 
1. Easy Solubility in cold and hot water. 
2. Fine film forming properties. 
3. Resistance to oil greases and solvents. 
4. Better thickening action. 
5. Physiological inertness 
6. Anionic character 
7. Binding properties 
8. Suspending characteristics. 
9. Gives transparent film. 
10. Acts as a protective colloid reducing water losses. 
 
Polymer:  SODIUM ALGINATE 
Nonproprietary Name: 
 BP: Sodium Alginate 
 Ph. Eur: Sodium Alginate 
 USP-NF: Sodium Alginate 
Synonyms: algin, alginic acid, sodium salt, sodium polymannuronate 
Chemical Name: Sodium alginate 
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Empirical Formula:  
Sodium alginate consists chiefly of the sodium salt of alginic acid, which is a mixture of 
polyuronic acids composed of residues of D-mannuronic acid and L-guluronic 
Structure: 
   
Molecular formula: （C6H7O6Na) 
Description:  
 White or light yellow, vagiform power, odorless, tasteless, dissolve in water, insoluble in 
ethanol and ether. 
Method of Manufacture: 
  Alginic acid is extracted from brown seaweed and is neutralized with sodium bicarbonate 
to form sodium alginate. 
Acidity/alkalinity:   pH 7.2 for a 1% w/v aqueous solution. 
Functional Category: 
Stabilizing agent, suspending agent, tablet and capsule disintegrate, tablet binder, viscosity 
increasing agent. 
Applications in Pharmaceutical Formulation or Technology: 
Sodium alginate is used in a variety of oral and topical pharmaceutical formulations. In tablet 
formulations, sodium alginate may be used as both a binder and disintegrate. It has been used as 
a diluent in capsule formulations. Sodium alginate has also been used in the preparation of 
sustained-release oral formulations since it can delay the dissolution of a drug from tablets, 
capsules and aqueous suspensions.  
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Description: 
Sodium alginate occurs as an odorless and tasteless, white to pale yellowish-brown colored 
powder. 
 Solubility: Practically insoluble in ethanol (95%), ether, chloroform, and ethanol or water 
mixtures in which the ethanol content is greater than 30%. Slowly soluble in water, forming a 
viscous colloidal solution. 
 Viscosity (dynamic): Various grades of sodium alginate are commercially available that yield 
aqueous solutions of varying viscosity. Typically, a 1% w/v aqueous solution, at 20
0
C, will have 
a viscosity of 20–400 mPas (20–400 cP).  
 Stability and Storage Conditions: 
Sodium alginate is a hygroscopic material, although it is stable if stored at low relative humidity 
and a cool temperature.  
Incompatibilities: 
Sodium alginate is incompatible with acridine derivatives, crystal violet, phenyl mercuric acetate 
and nitrate, calcium salts, heavy metals, and ethanol in concentrations greater than 5%.  
Method of Manufacture: 
Alginic acid is extracted from brown seaweed and is neutralized with sodium bicarbonate to 
form sodium alginate. 
 Safety: 
It is generally regarded as a nontoxic and nonirritant material, although excessive oral 
consumption may be harmful.  
Applications: 
 Sodium alginate is used in a variety of oral and topical pharmaceutical formulations. 
 In tablet formulations, sodium alginate may be used as both a binder and disintegrates 
 It  has been used as a diluent in capsule formulations  
 Sodium alginate has also been used in the preparation of sustained release oral 
formulations since it can delay the dissolution of a drug from tablets, capsules and 
aqueous suspensions. 
 In topical formulations, sodium alginate is widely used as a thickening and suspending 
agent in a variety of pastes, creams and gels as a stabilizing agent for oil-in-water 
emulsions. 
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 Sodium alginate has been used for the aqueous microencapsulation of drugs, in contrast 
with the more conventional microencapsulation techniques which use organic-solvent 
systems.   
 It has also been used in the formation of nanoparticles. 
 
Polymer: HYDROXY PROPYL METHYLCELLULOSE 
1. Nonproprietary Name: 
BP: Hypromellose 
USP: Hypromellose 
2.  Synonyms: 
Hydroxypropyl methylcellulose, HPMC, hypromellosum, Methocel, methylcellulose propylene 
glycol ether, methyl hydroxypropylcellulose, Metolose, MHPC.  
3. Chemical Name:  Cellulose hydroxypropyl methyl ether. 
4. Empirical Formula and Molecular Weight: 
The PhEur 6.3 describes hypromellose as a partly O-methylated and O-(2-hydroxypropylated) 
cellulose.  Molecular weight is approximately 10,000 – 1,500,000. 
5. Structural Formula:             
 
Structure of HPMC 
Where R is H, CH3, or CH3CH (OH) CH2 
 
6. Applications in Pharmaceutical Formulation or Technology: 
Hypromellose is widely used in oral, ophthalmic, nasal and topical pharmaceutical 
formulations. In oral products, hypromellose is primarily used as a tablet binder, in film-coating, 
and as a matrix for use in extended release tablet formulations. Concentrations between 2% and 
5% w/w may be used as a binder in either wet- or dry-granulation processes. High-viscosity 
grades may be used to retard the release of drugs from a matrix at levels of 10–80% w/w in 
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tablets and capsules. Hypromellose is also used in liquid oral dosage forms as a suspending and 
or thickening agent at concentrations ranging from 0.25 – 5.0%.  
7. Description: 
Hypromellose is an odorless and tasteless, white or creamy-white fibrous or granular powder. 
8. Solubility: 
 Soluble in cold water, forming a viscous colloidal solution; practically insoluble in hot water, 
chloroform, ethanol (95%) and ether, but soluble in mixtures of ethanol and dichloromethane, 
mixtures of methanol and dichloromethane. 
9. Viscosity (dynamic): 
A wide range of viscosity types are commercially available. Aqueous solutions are most 
commonly prepared. 
Typical viscosity values for 2% (w/v) aqueous solutions of methocel (Dow Chemical Co.) 
viscosities measured at 20ºC  
Methocel grade  
 
Viscosity(cps)  
K4 M  
 
4000  
 
K15M  
 
15000  
 
K100M  
 
100000  
 
10. Stability and Storage Conditions: 
Hypromellose powder should be stored in a well-closed container, in a cool, dry place. 
11. Safety: 
Hypromellose is generally regarded as a nontoxic and nonirritating material, although excessive 
oral consumption may have a laxative effect. 
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    5.0. RESEARCH ENVISAGED 
5.1. Aim of Work: 
The objective of this study is to develop, characterize, and evaluate mucoadhesive 
microspheres of Ciprofloxacin employing various mucoadhesive polymers for prolonged 
gastrointestinal absorption. 
Mucoadhesive are preferred because immobilization of drug carrying particles at the 
mucosal surface would result in: 
 A prolonged residence time at the site of action or absorption. 
 A localization of the drug delivery system at a given target site. 
 An increase in drug – concentration gradient due to intestine contact of the particles 
with the mucosal surface. 
A direct contact with intestinal cells, which is the step earlier to particle absorption. 
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5.2. Plan of Work: 
 The present work was carried out to prepare and evaluate microperticulate drug 
delivery system Ciprofloxacin HCl of using Sodium Carboxy Methyle Cellulose, Sodium 
Aliginate and Hydroxy Propyle Methyle Cellulose in various proportions. The following 
experimental protocol was therefore designed to allow a systemic approach to the study. 
 Procurement of drug and raw materials. 
 Pre- formulation studies for possible drug or polymer interaction by IR analysis and 
UV. 
 Preparation of standard curves.  
 Preparation of mucoadhesive microspheres by Emulsification Solvent Evaporation 
technique.  
 Drug release study using suitable in-vitro model. 
 Evaluation of the various properties of Mucoadhesive microspheres. 
a. Particle size analysis. 
b. Bulk density. 
c. Drug Entrapment efficiency. 
d. Drug Content. 
e. In-vitro mucoadhesion study 
f. Kinetic modeling. 
g. Scanning Elecron Microscopy 
h. HPLC 
i. Stability Studies 
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6.0. MATERIALS AND EQUIPMENTS: 
MATERIALS: 
 The Materials used For the Process are as follows: 
List of chemicals: Table: 1 
S.No Chemicals Company 
1. Ciprofloxacin HCl Darwin Formulations, Mumbai, India 
2. Sodium CMC Reachem laboratory chemicals Pvt.Ltd, India 
3 Sodium Aliginate Rajesh Chemicals, Mumbai, India 
4 HPMC Dr.Reddy’s Lab Pvt.Ltd, Hyderabad, India 
5. Seasem oil AR grade, India 
6. Light Liquid paraffin Qualigens fine chemicals, Mumbai, India 
8. Span 20 Sd fine –chem limited, Mumbai, India 
9. n-Hexane Sd fine –chem limited, Mumbai, India 
 
List of Equipment’s: Table: 2 
S.No Equipment Company 
1. Glass ware DELTA ( Borosilicate Glass) 
2. UV Spectrophotometer  Elico LI 120 
3. Mechanical stirrer Remi motors 
4. USP type 11 Station Dissolution 
apparatus 
ELECTRO Lab  
5. Balance Dolphin Digital Balance 
6. FTIR KBR press model M15 
7. HPLC SPD-10 AVP, SHIMADZU 
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   7.0. EXPEREMENTAL INVESTIGATION 
Preformulation Study: 
7.1. Organoleptic properties
34
:
 
 
 Ciprofloxacin was observed for color, odor and taste. 
 7.2. Standard calibration curve of Ciprofloxacin HCl
34
:  
 Ciprofloxacin HCl can be estimated spectrometrically at 272 nm as it obeys Beer’s –
Lambert’s law limit is the range of 2-20 µg/ml. 
7.2.1. Preparation of 0.1 N Hydrochloric acid (pH 1.2):
 
8.5 ml of concentrated hydrochloric acid was taken and then diluted with distilled 
water up to 1000 ml (0.1N HCl). 
A. Stock Solution 
100 mg of Ciprofloxacin HCL was dissolved in 100 ml of 0.1N HCl. So, as to get a 
stock solution of 1000 g/ml concentration. 
 
B. Standard Solution 
10 ml of stock solution was made to 100 ml with 0.1N HCl thus giving a 
concentration of 100 g/ml.  Aliquot of standard drug solution ranging from 0.2 ml to 1 ml 
were transferred in to 10 ml volumetric flask and were diluted up to the mark with 0.1N HCl.  
Thus the final concentration ranges from 2-10 g/ml.  Absorbance of each solution was 
measured at 272 nm against 0.1N HCl as a blank.  A plot of concentrations of drug vs. 
absorbance was plotted. 
 
 7.3. Drug-excipients interaction study by FTIR Spectrum
45
: 
 FTIR study was carried out for Ciprofloxacin as well as for Excipients (Sodium CMC, 
Sodium Alginate, Hydroxy propyl Methyl Cellulose). 
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Emulsification Solvent evaporation technique 
 Dissolve the coated substance in a volatile solvent (immiscible with  liquid 
Manufacturing Vehicle, LMV) 
 Dissolve or disperse the core material in coating polymer solution with agitation. 
 Disperse the core coat mixture in LMV with continuous agitation. 
 Heat the whole mixture to evaporate the solvent for the polymer. 
 Cross linking with glutaraldehyde, formaldehyde etc., 
7.4. Emulsification Solvent Evaporation Method for Preparation of 
Mucoadhesive microspheres
46, 51
: 
Mucoadhesive microspheres were prepared by the w/o emulsification by solvent 
evaporation technique. The drug was dissolved in each polymeric aqueous solutions. The 
solutions were poured into 200 ml of sesame oil containing span-20 (0.5%) as an 
emulsifying agent. The aqueous phase was emulsified into the oily phase by stirring the 
system in 500 ml beaker at 500 rpm by mechanical stirrer. The beaker and its contents were 
heated on the hot plate at 80˚C. Continues stirring and heating were maintained for 4 hrs 
until the aqueous phase was completely removed by evaporation. The light mineral oil was 
decanted and collected microspheres were washed three times with 100 ml aliquots of n-
hexane, filtered through what man filter paper, dried in an oven at 50˚ C for 2 hrs and 
stored in a dessicator at room temperature. Microspheres were prepared using Sodium 
Alginate, Sodium Carboxyl Methyl Cellulose and HPMC polymers. 
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Composition of Mucoadhesive Microspheres of Ciprofloxacin HCl: 
Table: 3 
Sl. No Formulations Drug (mg) 
Sodium 
CMC 
(mg) 
Sodium 
Alginate 
(mg) 
HPMC 
(mg) 
Drug 
Ratio 
1 F1 500 500 ----- ----- 1:1 
2 F2 500 1000 ----- ----- 1:2 
3 F3 500 ----- 500 ----- 1:1 
4          F4 500 ----- 1000 ----- 1:2 
5 F5 500 ----- ----- 500 1:1 
6 F6       500 ----- ----- 1000 1:2 
 
 Formulation Procedure: 
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7.5. Evaluation of microspheres 
7.5.1. Bulk density (Db)
 12, 15
: 
It is the ratio of powder to bulk volume. The bulk density depends on particle size 
distribution, shape and cohesiveness of particles. Accurately weighed quantity of spheres was 
carefully poured into graduated measuring cylinder through large funnel and volume was 
measured which is called initial bulk volume. Bulk density is expressed in gm/cc and is given 
by,                
Db = M / Vo Where, Db = Bulk density (gm/cc) 
                                  M =Mass of powder (g) 
                                  Vo = Bulk volume of powder (cc) 
Bulk density (gm/cm
3 
) = weight of sample / Final volume 
 
7.5.2. Particle Size Analysis
18, 32
: 
A minute quantity of microsphere was spread on a clean glass slide. This was placed 
in stage of calibrated optical microscope; approximately 100 microspheres were counted. The 
particle size was calculated in triplicate for each batch using the formula 
Arithmetic mean              = Σnd / sum of number of particle 
             Volume surface diameter = Σnd3/ Σ nd2 
 
7.5.3. Drug content
32
: 
                             Ciprofloxacin content in the microspheres was estimated by a UV 
Spectrophotometric method based on the measurement of absorbance at 272 nm in distilled 
water. Microspheres equivalent to 50 mg were weighed and added in 100 ml of distilled 
water. The volumetric flask was stirred continuously for 24 hrs on a magnetic stirrer. 
Dilutions of the above solutions were made suitably and measured for the drug content. 
 
 
 
EXPERMENTAL INVESTIGATION 
 
Department of pharmaceutics, Nandha college of pharmacy. Page 43 
 
7.5.4. Drug Loading and Entrapment Efficiency
13, 28,32
: 
 Ciprofloxacin microspheres were weighed and dissolved in 0.N HCl. The UV 
absorbance of the solution was measured using a (Shimadzu UV-100 serious, Japan) 
272 nm. Drug loading and encapsulation efficiency were determined by following 
formula and the values were expressed as percentage. 
 
7.5.5. In-vitro wash-off test for mucoadhesion
32
: 
                             The mucoadhesive properties of the microspheres were evaluated by in 
vitro wash-off test. A 1-cm by 1-cm piece of rat stomach mucosa was tied onto a glass slide 
(3-inch by 1-inch) using thread. Microspheres were spread onto the wet, rinsed, tissue 
specimen and the prepared slide was hung onto one of the groves of a USP tablet 
disintegrating test apparatus. The disintegrating test apparatus was operated such that the 
tissue specimen was given regular up and down movements in a beaker containing the 
simulated gastric fluid (pH 1.2). At hourly intervals at 37˚C, up to 3.5 hrs, the number of 
microspheres still adhering onto the tissue was counted. Percent mucoadhesion was given by 
the following formula. 
% mucoadhesion = (no. of microspheres remains / no. of applied microspheres) ×100 
7.5.6. In-vitro drug release study
42
: 
Procedure: 
 In-vitro drug release studies of Ciprofloxacin HCl were conducted for a period of 12 
hrs using USP XXIII type II apparatus at 37 + 0.5
0 
C and at 50 rpm speed in 900 ml of 0.1 N 
HCl (pH1.2). An aliquot of the sample was periodically with drawn at suitable time interval 
and volumes were replaced with fresh dissolution medium in order to maintain the sink 
condition. After withdrawing at predetermined time interval for 12 hrs, the samples were 
analyzed by a   UV spectrophotometer (ElicoLI 120, Mumbai, India) at 272 nm. The study 
was performed in triplicate. 
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7.5.7. Kinetic Analysis of In-Vitro Release Rates of Ciprofloxacin HCl
37, 38
: 
1. Zero order kinetics: 
Drug dissolution from pharmaceutical dosage forms that do not disaggregate and 
release the drug slowly, assuming that the area does not change and no equilibrium 
conditions are obtained can be represented by the following equation –  
Q t = Q o + K o t 
Where Q t = amount of drug dissolved in time t, Q o = initial amount of drug in the 
solution and K o = zero order release constant. 
2.  First Order Kinetics: 
First – order release would be predicted by the following equation:- 
Log C = log C0 – Kt / 2.303 
Where, C = Amount of drug remained at time‘t’ 
C0 = Initial amount of drug. 
  K = First – order rate constant (hr-1). 
When the data is plotted as log cumulative percent drug remaining versus time yields a 
straight line, indicating that the release follow first order kinetics.  The constant ‘K’ can be 
obtained by multiplying 2.303 with the slope values. 
3. Higuchi model: 
Higuchi developed several theoretical models to study the release of water-soluble 
and low soluble drugs incorporated in semisolids and or solid matrices. Mathematical 
expressions were obtained for drug particles dispersed in a uniform matrix behaving as the 
diffusion media. And the equation is  
Q t  = KH. t 
1/2
 
Where Q t  = Amount of drug released in time t, K H = Higuchi dissolution constant. 
 
4. Krosmeyer and Peppas release model: 
To study this model the release rate data are fitted to the following equation 
Mt / M  = K.t 
n
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Where Mt / M  is the fraction of drug release, K is the release constant, t is the 
release time and n is the Diffusional exponent for the drug release that is dependent on the 
shape of the matrix dosage form. 
If the exponent n = 0.5 or near, then the drug release mechanism is Fickian diffusion, 
and if n have value near 1.0 then it is non-Fickian diffusion. 
 
Table 4: Mechanism of Drug Release as per Korsmeyer Equation / Peppa’s     Model                                                        
S. No. N Value Drug release 
1. 0.45 Fickian release 
2. 0.45 <n <0.89 Non – Fickian release 
3. n> 0.89 Class II transport 
 
7.5.8. Morphology
 32
: 
The external and internal morphology of the Microspheres were analysed by scanning 
electron microscopy (SEM Hitachi S 502, Tokyo, Japan).  
 
7.5.9. HPLC analysis of Ciprofloxacin HCl
42, 47
: 
Drug: 
The reference sample of Ciprofloxacin HCl  was supplied by Darwin Formulations, 
Mumbai, India. The branded tablets formulation of Ciprofloxacin (Baycip) was purchased 
from local market. 
 
Preparation of Mobile Phase: 
 Weigh (0.13 gm) potassium dihydrogenphaspate and dissolve in 100 ml of HPLC 
water to get the concentration of 0.01 M for the analysis the mobile phase consists of 
acetonitrile and 0.01 M potassium dihydrogenphaspatein the ratio of 70:30 v/v and adjusted 
the pH in to 4.5 by using glacial acidic acid and flow rate of 1 ml/min. 
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Preparation of Standard Solution: 
 Primary stock solution of ciprofloxacin prepared by dissolving 100 mg in 100 ml of 
mobile phase to get the concentration of 1 mg/ml. Further dilute 10 ml of this to 100 ml with 
mobile phase to get 100 mg/ml of ciprofloxacin HCl respectively. Ciprofloxacin shows 
maximum absorbance in UV at 272 nm. 
 
Preparation of sample solution (Assay of Ciprofloxacin HCl in Microspheres): 
 Weighed 50 mg of ciprofloxacin and dissolved in 50 ml of mobile phase to get 1000 
µg/ ml. Further dilute with 10 ml with mobile phase to get the concentration of 100 µgm/ml. 
The mixture was filtered through whattmann’s filter paper No: 40 at each step and then 
sonicated it for 15 min. observe the absorption at the detector wave length of 272 nm.  
 
Chromatographic Conditions: 
The HPLC system consisted of a pump (VL cipro casting) programmed by a system 
controller (model Spinchran), an ultraviolet-visible spectrophotometric detector (LCATVP), 
and a recorder (model CR501) from Shimadzu (Tokyo, Japan). The separation was carried 
out using a phenomnx (C180 pH stable column (Phase Separations, Hyd), 15 cm long. The 
mobile phase consisted of glacial acetic buffer: acetonitrile: methanol (85:10:5 
vole/vole/vole) with an apparent pH adjusted to 4.5 with Glacial acetic acid. The flow rate 
was maintained at 1.5 mL.min-1 and the column effluent was monitored at 272 nm.  
 
Stationary Phase Phenomnx C18 Analytical column 
(250×4.6 mm, 5 µm) 
Mobile Phase ACN: 0.01 M Potassium dihydrogen 
phosphate (70:30 v/v) and maintain 
the pH up to 4.5 by using glacial 
acetic acid. 
Flow rate 1 ml/min 
Dection wave length 272 nm 
Injection volume  20 µl 
Temperature Ambient temperature 
Run Time 15 min 
    Table 5: Chromatographic Conditions 
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7.5.10. Stability Study
39
:
 
Samples from each batch were withdrawn after the definite time intervals and the 
residual amount of drug in the vesicles was determined. Stability data of three formulations 
were further analyzed for significant difference by paired t-test.
 
All the batches of Ciprofloxacin microparticles were tested for stability. The 
preparations were divided into 3 sets and were stored at 5-8
0 
C (refrigerator) 27
0 
C and at 40
0 
C. After 15, 30 and 60 days drug content of all the formulations was determined by the 
method discussed previously in entrapment efficiency section. 
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   8.0. RESULT AND DISCUSSION 
    The aim of the study was to design and evaluation of SRM microspheres of 
ciprpfloxacin HCl were prepared by emulsification  solvent evaporation technique using 
span-20(0.5%) in seasem oil incorporating mucoadhesive polymers like sodium carboxy 
methyl cellulose, sodium alginate and HPMC with various ratios. Finally to carry out the 
stability studies for the selected formulations. The microspheres were prepared by using 
generally approved excipients that were compatible with the ciprofloxacin a fluoroquinolone 
analog. 
Preformulation Parameters: 
Organoleptic properties:
 
 
 Ciprofloxacin was observed for color, odor and taste. 
Determination of λmax of Ciprofloxacine HCl : 
 
Fig 1:  Spectrum of Ciprofloxacine HCl 
 Ciprofloxacine HCl drug solution in pH 1.2 (0.1N HCl) was scanned using UV-
Spectrophotometer between the range 210-400 nm using pH 1.2 as blank and the maximum 
absorbance (λ max) was found at 272nm. It was concluded that the drug has λmax of 272 nm, 
which is exactly 272 nm as reported. 
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Calibration curve  of Ciprofloxacin HCl: 
Table 6: 
 
 
 
 
  
   Fig 2:Calibration curve of an Ciprofloxacine HCl 
From the standard curve of ciprofloxacin it was observed that the drug obeys Beer’s 
law in the range of 2-20 µg/ml. 
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Concentration 
Standard Graph Of Ciprofloxacin HCl 
S.No Concentration(µg/ml) Absorbance 
1 0 0 
2 2 0.161 
3 4 0.376 
4 6 0.552 
5 8 0.743 
6 10 0.901 
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FT-IR Studies: 
FT-IR Spectra of  Drug: Ciprofloxacine HCl 
 
 Fig 3:  FTIR Spectroscopy of pure drug 
 
Fig 4:FT-IR Spectra of  Polymer: Sodium CMC
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Fig 5:FT-IR Spectra of  Polymer: Sodium Aliginate 
 
 
 
 
Fig 6:FT-IR Spectra of Polymer: HPMC
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Fig 7:FT-IR Spectra of Drug with Sodium CMC:
 
 
 
Fig 8:FT-IR Spectra of Drug with Sodium Aliginate
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Fig 9:FT-IR Spectra of Drug with HPMC:
 
 
Table 7: 
 
Drug polymer interaction was checked by comparing the IR spectra of the 
formulations with the IR spectra of the pure drug. There was no significant change in the 
functional groups between the IR spectrum of the pure drug and also no additional peaks 
S. 
No 
Type of 
bond 
Standard 
wave 
number 
 Observed wave number 
ciprofloxacin CIP + 
Sodium 
CMC 
CIP +Sodium 
Alginate 
CIP +HPMC 
1 C-H 
Alkanes 
(stretch) 
3000 - 2850 3010.98 2902.00 3011.95 2839.38 
2 -CH3 Bend 1450 1448.85 --- 1449.5 1443.77 
3 -CH2 Bend 1465 1385.90 1464.81 1471.09 1469.81 
4 Aromatics 3150-3050 3035.09 3035.49 3036.21 3035.46 
5 C=O 1725-1705 1708.02 1708.99 1624.12 1708.23 
6 C-O 1300-1000 1306.02 1026.16 1028.16 1045.45 
7 O-H 3650-3600 3624.31 3626.29 3624.33 3740.10 
8 N-H 3500-3100 3531.78 3532.44 3532.74 3531.81 
9 C-N 1350-1000 1345.39 1342.50 1344.43 1343.46 
10 O-H 3400 3374.81 3376.30 3368.79 3364.93 
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were seen in the selected formulations. This confirms that no interaction between drug and 
excipients. 
The drug-excipient interaction study was carried out using IR i.e. by KBr pellet 
method. In the drug-excipient interaction study, it was found that ciprofloxacin was having 
compatibility with all the excipients used in the formulation.  It was found that all peaks 
corresponding to different functional groups of pure drug were present in the drug-excipient 
mixture, this shows the absence of interaction between the drug and excipients listed in above 
table. 
 
Evaluation parameters: 
Table 8: Particle size, Bulk Density, Drug content, Entrapment efficiency and 
mucoadhesive  strenth: 
Formulation Particle Size 
(µm) 
Bulk 
Density 
(gm/cm) 
Drug 
content (%) 
Entrapment 
Efficiency 
(%) 
Muco 
Adhesive 
Strenth(%) 
F1 97.21±0.57 0.271±0.21 82.56±0.34 72.72±0.13 64.11±015 
F2 102.67±0.13 0.521±0.13 86.2±0.29 68.25±0.15 62.17±0.20 
F3 74.75±0.12 0.47±0.17 83.15±0.88 67.71±0.21 58.14±0.19 
F4 82.13±0.21 0.574±0.13 85.32±0.41 52.32±0.81 48.72±0.23 
F5 68.83±0.32 0.596±0.12 76.51±0.27 58.21±0.21 46.26±0.72 
F6 56.63±0.24 0.672±0.19 79.72±0.21 49.32±0.89 38.12±0.25 
 
Partical size Analysis: 
The particle size of the microspheres was determined by optical microscopy. The 
average particle size was found to be in the range of 61.4 to 199.9 µm. Batch F6 showed the 
least particle size of 56.63±0.24 µm which is due to spherical nature of microspheres as 
showed by the SEM. It was investigated that on increasing the concentration of polymer then 
particle size increases. The mean particle size of microspheres increased from 56.63±0.24 µm 
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to 102.67±0.13 µm with increase in concentration of polymer from 1 to 3%. The particle size 
of microspheres increased with the increase in the concentration of polymer, since at higher 
concentrations of the polymer solution dispersed into larger droplets, at concentrations lower 
than the optimum level the solution became less viscous and dispersed into various fine 
droplets that easily cosealed, resulting in larger microspheres. 
Drug content: 
The drug content estimation data for all the batches were found to be between 76.51 + 
1.27 to 86.2+ 1.2 which was found to be within the limit and the result are by increasing  
polymer concentration, increasing the particle size. 
Drug entrapment efficiency 
Drug content in different formulations was estimated by UV Spectrophotometric 
method. Percent drug loading efficiency of microspheres was found in the range of 
49.32±0.89 to 72.72±0.13. Formulation F1 containing Sodium CMC showed maximum 
percentage drug loading about 73 % whereas formulation F6 containing blend of HPMC 
showed minimum percentage of drug loading about 50% because these microspheres are 
small in size which results more loss of drug from surface during washing of microspheres. 
Rank order of % drug loading of various formulations was found to be as follows:  
                          F1 > F2 > F3 > F5 > F4 > F6 
Mucoadhesive Property: 
 The Mucoadhesive property of the microspheres was evaluated by in vitro adhesion 
testing methods called in-vitro wash off test. This test was done with the help of USP 
disintegration apparatus in which beaker contained 1.2 pH buffer solution. The numbers of 
microspheres adhering to the tissue were calculated after 30 min, 1 hr and hourly at 4 hr. 
After determination it was found that batch F1 showed highest percent 65% mucoadhesion 
than other batches. 
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In-vitro Drug Release Study: 
Table 9:Cumulative percentage drug release of formulations: 
Sl.No Time 
CIP+SodiumCMC 
(1:1) 
F1 
CIP+SodiumCMC 
(1:2) 
F2 
CIP+Aliginate  
(1:1) 
F3 
CIP+Aliginate 
(1:2) 
F4 
CIP+HPMC 
(1:1) 
F5 
CIP+HPMC 
(1:2) 
F6 
1 0 0 0 0 0 0 0 
2 1 18.389+0.45 16.487+0.35 25.652+0.12 24.188+0.36 34.985+0.45 39.213+0.25 
3 2 28.789+035 25.366+0.49 40.891+0.24 35.708+0.25 38.678+0.25 54.453+0.39 
4 3 43.473+0.26 48.766+0.25 57.813+0.26 52.274+0.35 52.027+0.35 56.391+0.45 
5 4 52.457+0.16 59.451+0.16 65.490+0.35 57.392+0.39 55.482+0.16 59.622+0.45 
6 5 65.754+0.46 68.955+0.38 72.804+0.25 58.256+0.45 57.235+0.28 64.607+0.25 
7 6 73.357+0.31 72.957+0.49 78.210+0.45 64.882+0.41 67.299+0.48 69.037+0.39 
8 7 78.752+0.42 75.759+0.28 83.114+0.31 69.584+0.43 72.651+0.42 72.637+0.19 
9 8 80.656+0.48 79.952+0.39 86.557+0.41 76.496+0.48 79.112+0.39 76.791+0.42 
10 10 81.854+0.28 80.542+0.25 9.966+0.26 87.921+0.34 84.835+0.19 79.284+0.37 
11 12 97.057+0.19 95.151+0.15 94.384+0.25 91.376+0.36 87.789+0.25 83.133+0.15 
*Avarage readings of triplicate studies. 
Fig 10:In-vitro drug release of microsphere:F1-F3 
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Fig 11 :In-vitro drug release of microsphere:F4-F6 
 
 
In-vitro dissolution studies were performed for all the formulations using USPXXII 
Tablet dissolution tester employing paddle type at 500 rpm using 900 ml of 0.1N HCl as 
dissolution medium. The samples withdrawn were analyzed by using UV spectrophotometer. 
As per the results (Table.9) of dissolution study formulations F1, F2, F3, F4, F5 and F6 
showed 97.05%, 96.15%, 94.38%, 91.37%, 87.78% and 83.13% respectively. This showed 
that the drug release from the caspule was sustained for 8 to 12 hr.  shows reasonable drug 
release when compared to other formulations. Also all other parameters like drug content and 
particle size for these formulations were within the range.  So, formulations F1 (Sodium 
CMC) were selected as the best formulation. The results are shown in table. 9. 
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Release kinetics: 
 Table 10: Model fitting for Optimized formulation F-1 
 
Time in 
hrs. 
 
Cumulative 
Drug 
Release (%) 
 
Log of % 
Drug 
unreleased 
 
Log t 
 
SQRT 
 
Log  % 
Cumulative 
Drug Release  
0 0 2 0 0 0 
1 
27.38 1.86 0 1 1.43 
2 
38.34 1.79 0.301 1.41 1.58 
3 
47.71 1.71 0.47 1.73 1.67 
4 
56.47 1.63 0.602 2 1.75 
5 
65.75 1.53 0.69 2.23 1.81 
6 
73.35 1.42 0.77 2.44 1.86 
7 
78.75 1.32 0.84 2.64 1.89 
8 
80.65 1.28 0.9 2.82 1.9 
10 
86.74 1.12 1 3.16 1.93 
12 
97.05 0.4 1.17 3.46 1.98 
 
 
Fig  12: Zero order approximation for the formulation F1 
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  Fig 13: First order approximation for the formulation F1 
 
 
 
  Fig 14: Higuchi’s approximation for the formulations F1 
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Fig 15: Korsmeyer-Peppas approximation for the formulations F1 
 
Table 11: Correlation coefficients of different mathematical models for formulations F-
1  
 
Formulation 
 
Zero order 
R
2
 
 
First order 
R
2
 
 
Higuchi 
R
2
 
 
Peppa’s 
R
2
 n value 
F1 0.894 0.916 0.993 0.986 0.49 
 
The in-vitro drug release data of the floating tablets were evaluated kinetically by zero 
order kinetics; first order kinetics, Higuchi plot and Peppas models. The regression 
coefficient  (R
2) value for Zero order, First order, Higuchi’s, and Peppas plots for formulation 
F1 were found to be 0.894, 0.916, 0.993, 0.986 (Fig:12-15 and Table. 11 ) also plots were 
found to be linear, which indicates that the drug release depended on the square root of the 
time and predominantly controlled by diffusion process. 
The mechanism of drug release is predicted by using Korsmeyer–Peppas equation. 
The n value of optimized formulation F1 was 0.49  and that of Fl formulation is less than 
0.85. This indicates that the drug release depends on swelling, diffusion, and erosion. All 
formulations follow the non-Fickian or anomalous type of diffusion. 
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Fig 16: Particle size analysis and Surface Morphology of Microparticles by SEM: 
  
Scanning Elrctron Microscopy of the prepared Ciprofloxacin  HCl microspheres to 
access their surface and morphological characteristics as shown [Figure 16]. 
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Fig 17: HPLC Analysis Of  Formulation F1 with Marketed Drug (Cipro): 
 
 
The Ciprofloxacin HCl content was determined by HPLC, and the experimental 
measurement was compared to the standard (Marketed) drug. The retention time for 
Ciprofloxacin (standard) was found to be 2.133 min and the sample (F1) was found to be 
2.130 min (fig no.17).   
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Stability Study: 
Table 11: Stability study data for F1  
 
 
 
 
 
 *
Average of three readings 
R.D.C. = Remaining Drug Content   # =    R.D.C.  In pH 1.2 (0.1N HCl) 
   
    Fig 18: Stability study 
Stability study is the important part of the study for any pharmaceutical formulation. 
There are procedures given for the stability study in ICH guidelines. In response to that 
stability study was carried out for the formulation F1(1:1)  by exposing it to temperature 5-8
o 
C, 27
o 
C and 40
0 
C for 2 months. The sample was analyzed for drug content at regular interval 
of two months and it was evident that there was no remarkable change in the drug content of 
Sr. No. Days 
% R.D.C. 
5-8
O
C 
% R.D.C. 
27 + 2
O
C 
% R.D.C. 
40 + 2
O
C 
1 
2 
3 
4 
5 
 
0 
15 
30 
45 
60 
 
100.00 + 0.00 
99.97 + 0.024 
99.84 + 0.032
 
 
99.63 + 0.045
 
 
99.24 + 0.038
 
 
 
100.00 + 0.00 
99.95 + 0.018 
99.81 + 0.026
 
99.54 + 0.031
 
98.93 + 0.021
 
 
100.00 + 0.00 
99.94 + 0.034 
99.73 + 0.041
 
98.44 + 0.037
 
98.80 + 0.026
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microparticles. Results show that formulation F1 was stable at mentioned temperatures. As 
the drug used, Ciprofloxacin HCl, is recommended to be stored below 25
0 
C, stability study 
has not been performed above ambient temperature.  
 
 
SUMMARY 
 
Department of Pharmaceutics, Nandha College of Pharmacy. Page 65 
 
 SUMMARY 
Sustained release drug delivery system are retained in the mucus membrane of GI for 
a longer time and assist in improving the sustained release of drugs that have an absorption 
window in the particular region of the GI tract as well as for controlling the release of the 
drug having site-specific absorption limitation.  
Ciprofloxacin HCl is a fluoroquinolone antibacterial agent which is highly effective 
against gram positive and gram negative bacteria, was used as a model drug to develop a 
sustained release formulation. Ciprofloxacin HCl exhibits pH dependent solubility. It is more 
soluble in acidic pH and slightly soluble at neutral or alkaline condition (intestinal 
environment). Hence an attempt was made to develop gastroretentive delivery system of 
ciprofloxacin which increase the bioavailability of ciprofloxacin and also to reduce frequency 
of administration, thereby improving patient compliance and therapeutic efficacy.  
In the present work, 6 different formulations were prepared by emulsificaion solvent 
evaporation method using three different polymers. They are Sodium Corboxy Methyl 
Cellulose(1:1 and 1:2), Sodium Alginate(1:1 and 1:2) and HPMC K100M (1:1 and 1:2). 
   Characterization of the drug was done by performing the UV spectroscopy and IR 
spectroscopy. IR spectrum of the pure drug was compared with that of physical mixture of 
drug with all the excipients used in the study. The results showed that there was no drug-
excipient interaction.  
All the prepared formulations were evaluated for Bulk density, Entrapment efficiency, 
drug content uniformity, Mucoadhesive strength, drug-polymer interaction, in-vitro drug 
release, Scanning electron microscopy, HPLC and short term stability studies.  
The dissolution studies were carried out for 12 hrs. As per the result of dissolution 
study formulations(Table:9) F1(1:1), F2(1:2), F3(1:1) and F4(1:2) showed reasonable release 
97.05, 95.151, 94.38 and 91.37 %, respectively. F1 and F2 showed good drug release profile, 
when compare to other formulations. Based on all these results, formulations F1 was selected 
as the best formulation. 
 The release kinetics were fitted to different mathematical models like Zero order, 
First order, Higuchi’s and Peppas plot. The selected formulations F1(1:1) follows Higuchi’s 
plot and slope (n) value of Peppas for these formulations were found to be in the range less 
than 0.85. This indicates that the drug release depends on swelling, erosion, and diffusion. 
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These formulations follow the non-fickian or anomalous type of diffusion. The drug-polymer 
ratios, viscosity of Sodium CMC, were found to influence the drug release.  
The drug polymer interactions of the optimized formulations were evaluated by FTIR. 
FTIR spectrum of pure drug was compared with that of formulations F1, F2, F3, F4, F5 and 
F6. All peaks corresponding to the different functional groups of pure drug were present in 
the formulations which indicate the absence of interaction between the drug and 
excipients(Table.7). 
The selected formulation F1 (1:1) was subjected for stability studies as per ICH 
guidelines. Formulations subjected for short term stability studies were checked for drug 
content,    entapment efficiency, Mucoadhesive strength and physical appearance for 90 days 
with an interval of 15 days. The formulations were found to be stable as no significant change 
was observed in the various evaluated parameters like HPLC of the formulation. 
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     CONCLUSION 
From past few years microparticles have been studied by many workers as a choice of 
sustained drug delivery system to provide a better drug bioavailability considering, high 
penetration property of the microparticles encapsulated agents through biological membrane and 
the stability of them. 
The present formulation study on Ciprofloxacin HCl is an attempt to prepare 
microparticle drug delivery system and evaluate its performance, In-vitro. The formulations were 
prepared, varying the ratios of polymer by emulsification solvent evaporation method. 
 An ideal or best formulation of microparticles is the one which gives high entrapment 
efficiency along with good stability, retention time (by using HPLC) and drug release profile. In 
the present study entrapment efficiency is found to be drug and polymer ratio dependent. The 
release rate is found to be depended on polymer concentration.  
In the present study entrapment efficiency is found to be dependent on drug and polymer 
ratio. The formulation F1 (1:1), which showed higher entrapment efficiency and muco adhesive 
strength provides desired drug release rate.  
  By these facts, study can be concluded by saying that Ciprofloxacin among the 
Mucoadhesive microspheres of Ciprofloxacin HCl prepared using Sodium CMC, Sodium 
Alginate, HPMC polymers using concentrations of 1:1 and 1:2 respectively, is a promising 
approach to enhancing the bioavailability of Ciprofloxacin HCl. The formulations F1, F2 showed 
reproducible results and the best Mucoadhesive profile with good surface morphology. The 
method employed gave spherical, discrete, and free flowing microspheres of Ciprofloxacin. 
Among all the formulations of microspheres, Sodium CMC  with 1:1 praportions showed the 
best sustained release  mucoadhesive effect. 
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